SUP-T1细胞
文献支持

SUP-T1细胞

收藏
  • ¥2450
  • BHcell(博辉生物)
  • BH-C2017
  • 2025年12月03日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    SUP-T1/SUP-T1细胞系/SUP-T1细胞株/SUP-T1人T淋巴瘤细胞

    Cell line name SUP-T1

    Synonyms Sup-T1; SUPT-1; SupT-1; Sup T-1; SUP T-1; SUP T1; Sup T1; SupT1; SUPT1; Tsup-1; VB; Stanford University Pediatric T-cell line 1

    Accession CVCL_1714

    Resource Identification Initiative To cite this cell line use: SUP-T1 (RRID:CVCL_1714)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Population: Caucasian.

    Characteristics: Has chromosomal translocations involving the genes for the alpha and beta subunits of TCR thus preventing surface expression of the endogenous TCR complex.

    Virology: Useful for studies of cell fusion and cytopathic effects of HIV-1 as well as cytopathic isolates of HIV-2.

    Virology: Susceptible to infection by herpesvirus 6B (HHV-6B) strain Z29 (PubMed=29304865).

    Doubling time: 28 hours (PubMed=3004618); ~30 hours (DSMZ=ACC-140); ~24-36 hours (BEI_Resources=ARP-100).

    Microsatellite instability: Stable (MSS) (Sanger).

    Microsatellite instability: Instable (MSI) (PubMed=31068700).

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Omics: Virome analysis using RNAseq.

    Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.

    Cell type: T-cell; CL=CL_0000084.

    PubMed=3107838; DOI=10.1016/0092-8674(87)90542-3

    Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G.

    pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

    Cell 49:659-668(1987)

     

    PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893

    Stranks G., Height S.E., Mitchell P., Jadayel D.M., Yuille M.A.R., De Lord C.F.M., Clutterbuck R.D., Treleaven J.G., Powles R.L., Nacheva E., Oscier D.G., Karpas A., Lenoir G.M., Smith S.D., Millar J.L., Catovsky D., Dyer M.J.S.

    Deletions and rearrangement of CDKN2 in lymphoid malignancy.

    Blood 85:893-901(1995)

     

    PubMed=8558920

    Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., Drexler H.G.

    The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.

    Leukemia 10:142-149(1996)

     

    PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7

    Burger R., Hansen-Hagge T.E., Drexler H.G., Gramatzki M.

    Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies.

    Leuk. Res. 23:19-27(1999)

     

    DOI=10.1016/B978-0-12-221970-2.50457-5

    Drexler H.G.

    The leukemia-lymphoma cell line factsbook.

    (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

     

    PubMed=11264379; DOI=10.1128/JVI.75.8.3903-3915.2001; PMCID=PMC114881

    Means R.E., Matthews T., Hoxie J.A., Malim M.H., Kodama T., Desrosiers R.C.

    Ability of the V3 loop of  serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.

    J. Virol. 75:3903-3915(2001)

     

    PubMed=17170727; DOI=10.1038/sj.leu.2404486

    Sandberg Y., Verhaaf B., van Gastel-Mol E.J., Wolvers-Tettero I.L.M., De Vos J., MacLeod R.A.F., Noordzij J.G., Dik W.A., van Dongen J.J.M., Langerak A.W.

    Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.

    Leukemia 21:230-237(2007)

     

    PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113

    Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

    Signatures of mutation and selection in the cancer genome.

    Nature 463:893-898(2010)

     

    PubMed=22292511; DOI=10.2174/187221512799303172

    Ho P., Dai K.-S., Chen H.-L.

    Molecular cloning of a novel PPEF-1 gene variant from a T-cell lymphoblastic lymphoma cell line.

    Recent Pat. DNA Gene Seq. 6:72-77(2012)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由博辉生物科技(广州)有限公司提供; *发表【英文论文】请标注:From Bohui Biological Technology (Guangzhou) Co., Ltd.

    图标技术资料

    资料下载:

    SUP-T1(BH-C2017).docx 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1680
    吉奥蓝图(广东)生命科学技术中心
    2025年11月26日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月15日询价
    ¥900
    上海泽叶生物科技有限公司
    2025年12月08日询价
    ¥150
    上海冠导生物工程有限公司
    2025年08月13日询价
    询价
    上海彩佑实业有限公司
    2025年06月23日询价
    文献支持
    SUP-T1细胞
    ¥2450